Literature DB >> 8408468

Correlation of microsomal antibodies with the intensity of the intrathyroidal autoimmune process in Graves' disease.

R Paschke1, M Vogg, S Swillens, K H Usadel.   

Abstract

Graves' disease is an organ-specific autoimmune disease, and intrathyroidal lymphocytes seem to be the major source of thyroid autoantibodies. Consequently, the intensity of the intrathyroidal lymphocytic infiltration is generally believed to reflect the activity of the autoimmune process. We, therefore, investigated the correlation of microsomal (enzyme immunoassay), thyroglobulin (RIA), and TSH receptor antibodies (RRA) with the degree of intrathyroidal infiltration by immunoglobulin G-producing plasma cells, activated T-cells, antigen-presenting cells, and the total number of lymphocytes. The immunocompetent cells were identified immunohistologically with monoclonal antibodies for immunoglobulins kappa and lambda, UCHL1, and the S100 antibody, respectively, in 26 thyroid glands of patients suffering from Graves' disease. The intensity of lymphocytic infiltration was determined by the point-counting method and by counting all lymphocytes and the labeled lymphocytes in 3 x 51 visual fields or 3 slides/thyroid gland. Microsomal antibodies correlated significantly (P = 0.001) with the total number of lymphocytes (r = 0.86), kappa (r = 0.71), lambda (r = 0.71), UCHL1 (r = 0.9), and S100 (r = 0.9) positive cells. These correlations were also significant for thyroglobulin antibodies. However, TSH receptor antibodies showed no significant correlations with any of the populations of immunocompetent cells. Patients with preoperatively undetectable TSH receptor or microsomal antibodies showed a broad variation of intrathyroidal infiltration by the immunocompetent cells investigated. Microsomal antibody titers, therefore, seem to reflect the intensity of the intrathyroidal autoimmune process in Graves' disease better than TSH receptor antibodies. However, the broad baseline variation in intrathyroidal infiltration observed with nondetectable thyroid antibodies will not always allow determination of the intensity of the intrathyroidal autoimmune process from microsomal or thyroglobulin antibody titers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408468     DOI: 10.1210/jcem.77.4.8408468

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

Review 1.  B-lymphocytes in autoimmune thyroid diseases (AITD).

Authors:  R Volpé
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

Review 2.  The measurement of antithyroid autoantibodies in the diagnosis and management of thyroid autoimmune disease.

Authors:  Z Kraiem
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

3.  [Incidence of immunogenic hyperthyroidism after radioiodine therapy of focal thyroid gland autonomy. Results of a multicenter study].

Authors:  M Weiss; R Görges; C Hirsch; J Bader; K Tatsch; K Hahn
Journal:  Med Klin (Munich)       Date:  1999-05-15

4.  Thyroid autoantibodies are rare in nonhuman great apes and hypothyroidism cannot be attributed to thyroid autoimmunity.

Authors:  Holly Aliesky; Cynthia L Courtney; Basil Rapoport; Sandra M McLachlan
Journal:  Endocrinology       Date:  2013-10-03       Impact factor: 4.736

5.  Thyroid peroxidase autoantibodies are associated with a lesser likelihood of late reversion to hyperthyroidism after successful non-ablative treatment of Graves' disease in Croatian patients.

Authors:  M Stefanic; I Karner
Journal:  J Endocrinol Invest       Date:  2014-01-08       Impact factor: 4.256

6.  Thyrotropin receptor antibodies in black South African patients with Graves' disease and their response to medical therapy.

Authors:  M Zouvanis; V R Panz; W J Kalk; B I Joffe
Journal:  J Endocrinol Invest       Date:  1998-12       Impact factor: 4.256

7.  99mTc-interleukin-2 scintigraphy in normal subjects and in patients with autoimmune thyroid diseases: a feasibility study.

Authors:  M Chianelli; S J Mather; A Grossman; R Sobnak; A Fritzberg; K E Britton; A Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-06-10       Impact factor: 9.236

8.  Soluble endothelium-associated adhesion molecules in patients with Graves' disease.

Authors:  C Wenisch; D Myskiw; B Parschalk; T Hartmann; K Dam; W Graninger
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

9.  Acupuncture for Hashimoto thyroiditis: study protocol for a randomized controlled trial.

Authors:  Shanze Wang; Jiping Zhao; Weimei Zeng; Wanqing Du; Tenghui Zhong; Hui Gao; Yi Xiao; Chao Yang
Journal:  Trials       Date:  2021-01-21       Impact factor: 2.279

10.  Epitopes specificity of antibodies to thyroid peroxidase in patients with Graves' disease, Hashimoto's thyroiditis and overlap-syndrome.

Authors:  Maira Espenbetova; Nina Kuzmina; Alexandr Zubkov; Venera Akhmetova; Zhanar Zamanbekova; Ainur Krykpaeva; Zhanar Zhumanbayeva; Kuralay Amrenova; Zhanargul Smailova; Natalya Glushkova
Journal:  J Clin Transl Endocrinol       Date:  2022-02-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.